Literature DB >> 2536621

Inhibition by cyclic AMP of guanine nucleotide-induced activation of phosphoinositide-specific phospholipase C in human platelets.

Y Yada1, S Nagao, Y Okano, Y Nozawa.   

Abstract

Phosphoinositide-specific phospholipase C (PLC) activity of human platelet membranes was activated by the nonhydrolyzable guanine nucleotide GTP gamma S. This activation did not occur in either membranes prepared from dibutyryl cyclic AMP-pretreated platelets (A-membranes) or those prepared from untreated cells and subsequently incubated with cyclic AMP (cAMP) (B-membranes). This cAMP-mediated inhibition was abolished in the presence of inhibitors of cAMP-dependent protein kinase (A-kinase), suggesting that the inhibition was due to phosphorylation of (a) protein component(s). No significant differences were observed in the basal PLC activity and the extent of pertussis toxin-catalyzed ADP-ribosylation among control membranes and the two types of phosphorylated membranes (A- and B-membranes). GTP-binding activities of Gs, Gi and GTP-binding proteins of lower molecular masses were not altered by the phosphorylation of the membranes. These findings suggest that a GTP-binding protein is involved in the GTP gamma S-mediated activation of PLC and that cAMP (plus A-kinase) inhibits this activation by phosphorylating a membrane protein (probably a 240-kDa protein), rather than the GTP-binding protein or PLC itself. It is likely that this phosphorylation uncouples the GTP-binding protein from PLC.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536621     DOI: 10.1016/0014-5793(89)80503-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Adenosine regulates a chloride channel via protein kinase C and a G protein in a rabbit cortical collecting duct cell line.

Authors:  E M Schwiebert; K H Karlson; P A Friedman; P Dietl; W S Spielman; B A Stanton
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

2.  P1,P4-dithio-P2,P3-monochloromethylene diadenosine 5',5'''-P1,P4-tetraphosphate: a novel antiplatelet agent.

Authors:  S W Chan; S J Gallo; B K Kim; M J Guo; G M Blackburn; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Translocation-independent activation of protein kinase C by platelet-activating factor, thrombin and prostacyclin. Lack of correlation with polyphosphoinositide hydrolysis in rabbit platelets.

Authors:  H Salari; V Duronio; S Howard; M Demos; S L Pelech
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

4.  Phorbol ester and the actions of phosphatidylinositol 4,5-bisphosphate specific phospholipase C and protein kinase C in microsomes prepared from cultured cardiomyocytes.

Authors:  J T Meij; K Bezstarosti; V Panagia; J M Lamers
Journal:  Mol Cell Biochem       Date:  1991-06-26       Impact factor: 3.396

5.  The effects of elevated cyclic AMP levels on histamine-H1-receptor-stimulated inositol phospholipid hydrolysis and calcium mobilization in the smooth-muscle cell line DDT1MF-2.

Authors:  J M Dickenson; T E White; S J Hill
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

6.  Gastric vagal afferent modulation by leptin is influenced by food intake status.

Authors:  Stephen J Kentish; Tracey A O'Donnell; Nicole J Isaacs; Richard L Young; Hui Li; Andrea M Harrington; Stuart M Brierley; Gary A Wittert; L Ashley Blackshaw; Amanda J Page
Journal:  J Physiol       Date:  2012-12-24       Impact factor: 5.182

7.  S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells.

Authors:  R Heller; F Bussolino; R Calvino; D Ghigo; P Alessio; R Todde; R Fruttero; G Pescarmona; A Gasco; U Till
Journal:  Agents Actions       Date:  1993-11

8.  Endogenous expression of histamine H1 receptors functionally coupled to phosphoinositide hydrolysis in C6 glioma cells: regulation by cyclic AMP.

Authors:  M C Peakman; S J Hill
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.